Lonza Group has been a dominant player in the contract development and manufacturing space for decades. We think the outlook for Lonza looks bright, especially as drug manufacturing becomes more ...

“So, we need to increase efficiency on the process development side. While automation is one way of doing that, a much more efficient solution is to use in silico process development data to increase ...

Luckily, the hiring process proceeded smoothly and Charles van Zyl joined as chief executive from Belgian pharma company UCB (BE:UCB) in 2023, while Joerg Hornstein has been in post as chief finance ...

Clinical data management companies play a crucial role in the healthcare sector by ensuring the accurate collection, validation, and analysis of clinical trial data. Their work enhances research ...

We assign Teva a Morningstar Uncertainty Rating of High, which largely reflects our quantitative analysis of the firm, based on the return ranges used by our star rating system, as well as our ...

The pharmaceutical industry is on the verge of a significant transformation due to the emergence of artificial intelligence ...

Wen Shuhao helped speed up the development of Pfizer’s Covid oral drug, Paxlovid. Now the chairman of Xtalpi wants to help ...

Sage Therapeutics has rejected the unsolicited acquisition offer it received earlier this month from longtime partner Biogen ...

With continued investment and growing buzz from the industry, the AI hype is expected to extend through 2025 and beyond.

Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...

Pharmaceutical firms that specialize in utilizing AI to speed up the drug discovery process are soaring today.

"Delphine's breadth of pharmaceutical development experience ... the risks inherent in the drug development process, the risks regarding the accuracy of our estimates of expenses and timing of ...